Small Pharma

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds

Author: Editorial 6th April 2023 0 Comments

Nina Massey reports for The Independent: “A psychedelic drug that gives trips lasting half an hour improves the symptoms of moderate to severe depression for up to six months, early trial results suggest. Biotechnology company Small Pharma announced the results of…
Read more

collaborative practice

depression, Dimethyltryptamine, Nina Massey, Psychedelic-assisted therapy, Robin Carhart-Harris, Small Pharma, The Independent

Psychedelic therapy could ‘reset’ depressed brain

Author: Editorial 18th March 2021 0 Comments

Rachel Schraer reports for the BBC: “A powerful hallucinogenic drug known for its part in shamanic rituals is being trialled as a potential cure for depression for the first time. Participants will be given the drug DMT, followed by talking therapy….
Read more

collaborative practice

ayahuasca, BBC, Carol Routledge, depression, DMT, psychedelic drugs, Psychedelic-assisted therapy, Rachel Schraer, Research, Small Pharma

Looking for fresh articles?

Psychedelic drug trip improves symptoms of depression for six months, breakthrough study finds

Psychedelic therapy could ‘reset’ depressed brain